Cargando…
HSH2D contributes to methotrexate resistance in human T-cell acute lymphoblastic leukaemia
Acute lymphoblastic leukaemia (ALL) is a malignant proliferative disease that originates from B-lineage or T-lineage lymphoid progenitor cells. Resistance to chemotherapy remains an important factor for treatment failure. The aim of the present study was to investigate drug resistance in T-cell ALL...
Autores principales: | Wang, Jing, Xiong, Yiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551555/ https://www.ncbi.nlm.nih.gov/pubmed/33000278 http://dx.doi.org/10.3892/or.2020.7772 |
Ejemplares similares
-
Absorption of methotrexate under standardized conditions in children with acute lymphoblastic leukaemia.
por: Pinkerton, C. R., et al.
Publicado: (1980) -
Serum profiles of methotrexate after its administration in children with acute lymphoblastic leukaemia.
por: Pinkerton, C. R., et al.
Publicado: (1982) -
The influence of serum methotrexate concentrations and drug dosage on outcome in childhood acute lymphoblastic leukaemia.
por: Pearson, A. D., et al.
Publicado: (1991) -
Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children
por: Kyvsgaard, Nini, et al.
Publicado: (2019) -
Selective aggregation of the splicing factor Hsh155 suppresses splicing upon genotoxic stress
por: Mathew, Veena, et al.
Publicado: (2017)